Financials
- Market Capitalization 21.01 M
- Employee 14
- Founded 2008
- CEO Steven C. Quay
- Website www.atossatherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002NCD8C8
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4584 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.44 USD | -0.22% | +2.60% | -1.90% | +129.74% | 21.76 M USD | ||
| 4592 | SKYE Skye Bioscience, Inc. - Common Stock | 0.61 USD | -1.61% | -14.08% | -16.44% | -23.75% | 21.44 M USD | ||
| 4603 | CLRB Cellectar Biosciences, Inc. - Common Stock | 2.61 USD | -0.76% | -6.79% | +6.10% | -16.88% | 20.86 M USD | ||
| 4614 | TVGN Tevogen Bio Holdings Inc. - Common Stock | 4.78 USD | -4.78% | -17.01% | -49.95% | +288.62% | 20.02 M USD |